Baton Rouge firm completes acquisition of Mexican specialty drug maker

    OncBioMune Pharmaceuticals, a Baton Rouge-based firm that has developed a prostate cancer treatment known as ProsaVax, has completed the acquisition of Mexican specialty drug maker Vitel Laboratorios …


    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.